Get the Stockscreener App
8.19
7.20%
-0.635
After Hours:
8.35
0.16
+1.95%
Kura Oncology Inc stock is traded at $8.19, with a volume of 1.57M.
It is down -7.20% in the last 24 hours and up +32.10% over the past month.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
See More
Previous Close:
$8.825
Open:
$8.82
24h Volume:
1.57M
Relative Volume:
1.00
Market Cap:
$710.87M
Revenue:
-
Net Income/Loss:
$-168.09M
P/E Ratio:
-3.7742
EPS:
-2.17
Net Cash Flow:
$-138.01M
1W Performance:
-0.36%
1M Performance:
+32.10%
6M Performance:
+6.23%
1Y Performance:
-58.82%
1-Day Range:
$8.18
$8.84
1-Week Range:
$7.88
$8.90
52-Week Range:
$5.41
$21.40
Kura Oncology Inc Stock (KURA) Company Profile
Name
Kura Oncology Inc
Sector
Industry
Phone
(858) 500-8800
Address
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Compare KURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
8.19 | 709.13M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Guggenheim | Neutral |
| Feb-06-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-14-24 | Downgrade | Stifel | Buy → Hold |
| Dec-22-23 | Initiated | Mizuho | Buy |
| Aug-11-23 | Initiated | BofA Securities | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Perform |
| May-17-23 | Initiated | BTIG Research | Buy |
| Jan-31-23 | Initiated | Stifel | Buy |
| Jul-12-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-15-22 | Initiated | Jefferies | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Dec-07-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Nov-05-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Initiated | Credit Suisse | Outperform |
| May-05-20 | Initiated | Barclays | Overweight |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Nov-09-18 | Initiated | Piper Jaffray | Overweight |
| Aug-01-18 | Initiated | H.C. Wainwright | Buy |
| Oct-13-16 | Resumed | Leerink Partners | Outperform |
| Jan-22-16 | Initiated | JMP Securities | Mkt Outperform |
| Dec-30-15 | Initiated | Oppenheimer | Outperform |
| Dec-16-15 | Initiated | Citigroup | Buy |
View All
Kura Oncology Inc Stock (KURA) Latest News
Kura Oncology (NASDAQ:KURA) Shares Gap Up After Insider Buying Activity - MarketBeat
Jacobs Levy Equity Management Inc. Purchases 566,193 Shares of Kura Oncology, Inc. $KURA - MarketBeat
Troy Edward Wilson Acquires 50,000 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz - RTTNews
Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $24.10 - MarketBeat
Ieq Capital LLC Buys New Shares in Kura Oncology, Inc. $KURA - MarketBeat
EcoR1 Capital LLC Reduces Position in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. $KURA Shares Bought by Graham Capital Management L.P. - MarketBeat
Kura Oncology at H.C. Wainwright: Strategic Pipeline Developments By Investing.com - Investing.com Canada
Kura Oncology Inc. Shows Early Signs of Technical StrengthWatch List & Fast Gain Stock Tips - beatles.ru
Kura Oncology (NASDAQ:KURA) Stock Price Up 5%Time to Buy? - MarketBeat
LifeSci Capital Maintains Buy Rating on Kura Oncology (KURA) - MSN
RA Capital Management L.P. Cuts Position in Kura Oncology, Inc. $KURA - MarketBeat
Real time alert setup for Kura Oncology Inc. performance2025 Short Interest & Target Return Focused Stock Picks - Newser
Market reaction to Kura Oncology Inc.’s recent newsJuly 2025 Patterns & Capital Efficiency Focused Ideas - Newser
Is Kura Oncology Inc. stock entering bullish territory2025 Fundamental Recap & AI Driven Stock Reports - Newser
Does Kura Oncology Inc. align with a passive investing strategyJuly 2025 Trends & Weekly Watchlist for Consistent Profits - خودرو بانک
Can Kura Oncology Inc. benefit from deglobalization2025 Sector Review & Risk Managed Investment Strategies - خودرو بانک
Trexquant Investment LP Grows Position in Kura Oncology, Inc. $KURA - MarketBeat
Is it time to cut losses on Kura Oncology Inc.2025 Sector Review & Weekly High Conviction Ideas - Newser
Why is Kura Oncology Inc. stock going up2025 Trading Recap & Weekly Stock Performance Updates - خودرو بانک
Armistice Capital LLC Grows Position in Kura Oncology, Inc. $KURA - MarketBeat
Can machine learning forecast Kura Oncology Inc. recoveryTrade Risk Summary & Free Growth Oriented Trading Recommendations - Newser
Kura Flat on Inducement Awards - Baystreet.ca
Heatmap analysis for Kura Oncology Inc. and competitorsGap Up & Fast Entry Momentum Trade Alerts - Newser
Leading vs lagging indicators on Kura Oncology Inc. performanceJuly 2025 Breakouts & AI Based Trade Execution Alerts - Newser
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Kura Oncology Grants Stock Options to New Employees Under Inducement Plan - AInvest
Is Kura Oncology Inc. in a long term uptrend2025 Volume Leaders & Weekly Top Stock Performers List - خودرو بانک
Short interest data insights for Kura Oncology Inc.Weekly Trading Summary & Community Verified Trade Signals - Newser
Comparing Kura Oncology Inc. in custom built stock radarsInsider Buying & Comprehensive Market Scan Insights - Newser
Is Kura Oncology Inc. gaining market share2025 Top Decliners & Low Risk High Win Rate Stock Picks - خودرو بانک
Is this a good reentry point in Kura Oncology Inc.2025 Short Interest & Reliable Momentum Entry Alerts - Newser
Kura Oncology at Cantor Conference: Promising Pipeline and Strategic Vision By Investing.com - Investing.com Canada
Guggenheim initiates coverage on Kura Oncology stock with Neutral rating By Investing.com - Investing.com Canada
Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth - Benzinga
Should you wait for a breakout in Kura Oncology Inc.July 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Backtesting results for Kura Oncology Inc. trading strategiesJobs Report & Long Hold Capital Preservation Plans - Newser
How to use a screener to detect Kura Oncology Inc. breakoutsOil Prices & AI Forecast Swing Trade Picks - Newser
What data driven models say about Kura Oncology Inc.’s future - Newser
Using RSI to spot recovery in Kura Oncology Inc.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
Will Kura Oncology Inc. outperform tech stocksTreasury Yields & Verified Swing Trading Watchlists - خودرو بانک
Is Kura Oncology Inc. stock poised for growthJuly 2025 Selloffs & Free High Return Stock Watch Alerts - Newser
Can Kura Oncology Inc. reach resistance levels soonJuly 2025 Levels & Real-Time Volume Spike Alerts - خودرو بانک
Jump Financial LLC Cuts Stock Position in Kura Oncology, Inc. $KURA - MarketBeat
What are Kura Oncology Inc.’s technical support levels2025 Valuation Update & Breakout Confirmation Alerts - خودرو بانک
Kura Oncology to Host Events Showcasing Preclinical and Clinical Data on FTI Agents and Targeted Therapies - Quiver Quantitative
Real time scanner hits for Kura Oncology Inc. explainedWeekly Trade Recap & Daily Risk Controlled Trade Plans - Newser
Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program - The Manila Times
Kura Oncology Inc. stock trend outlook and recovery pathJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
Aug Spikes: Can Kura Oncology Inc. benefit from deglobalizationJuly 2025 Update & Stepwise Trade Signal Implementation - khodrobank.com
Kura Oncology Inc Stock (KURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):